Patients using GLP-1 RAs may experience dermatologic adverse side effects, including skin laxity, hair shedding, and facial ...

Daraxonrasib significantly prolonged survival in previously treated mPDAC, supporting its use as a new treatment option for patients with RAS-driven disease. Daraxonrasib prolongs overall and ...

Manufacturers in California must now use standardized phrases like: "best if used by" or "best if used or frozen by" to signal peak quality and "use by" or "use or freeze by" to flag safety.

Twenty-four weeks of bepirovirsen achieves a functional cure in approximately one-fifth of patients with chronic hepatitis B.

While the role of the gut-joint axis has been recognized in SpA, evidence shows diet should be used as an adjunct to ...

Same-day administration of COVID-19 and influenza vaccines is not associated with increased risk for adverse events.

Controlled attenuation parameter-measured hepatic steatosis independently predicts greater coronary artery disease complexity in patients with AMI. Patients with acute myocardial infarction (AMI) and ...

There was a significant inflection in call volume, with semaglutide exposures increasing an additional 9.9% per quarter after FDA approval. (HealthDay News) — Glucagon-like peptide-1 receptor agonist ...

Upadacitinib and infliximab provide the most rapid onset of symptom improvement among those with moderate to severe UC with no medical history of biologic therapy. Upadacitinib and infliximab have the ...

Anti-TNF therapy has the most favorable safety and disease-control profile during pregnancy, with vedolizumab and ustekinumab performing similarly.

Poor nocturnal sleep is independently associated with a substantially higher risk for MASLD in adults with type 2 diabetes.